This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
Ophthalmology Podcasts

The Macular Minute

Podcast Series

The Macular Minute Banner
Welcome to The Macular Minute
Your source for quick expert insights in medical retina

This is a Bayer-owned promotional podcast that offers bite-sized education for UK healthcare professionals. Listen now as we interview leaders in the field on key topics related to EYLEA® (aflibercept) 8 mg, including injection technique, patient experiences, treatment pathways and clinical audits. Tune in for insights delivered one minute at a time.

Prescribing information for EYLEA® (aflibercept) 8 mg can be found here.

Prescribing information for EYLEA® (aflibercept) 2 mg can be found here.

 

Meet our expert panel for this first series of The Macular Minute:

Richard Gale

Professor of Ophthalmology at York University and Honorary Consultant Ophthalmologist at Scarborough Teaching Hospitals NHS Foundation Trust

Rossella Anzidei

Consultant Ophthalmologist at University Hospitals Leicester NHS Trust

Hani Hasan

Consultant Ophthalmologist at Newcastle upon Tyne Hospitals NHS Foundation Trust

Sobha Sivaprasad

Consultant Ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust

Serena Salvatore

Consultant Ophthalmologist at University Hospitals Bristol and Weston NHS Foundation Trust

Bhavin Maru

Lead Nurse in Ophthalmology at Imperial College Healthcare NHS Trust

Click on the below cards to access The Macular Minute podcast episodes.

Implications of Reducing the Anti-VEGF Treatment Burden
with Hani Hasan
PP-EYL-GB-2541, December 2024
Approval Procedure for Introducing EYLEA® (aflibercept) 8...
with Rossella Anzidei
PP-EYL-GB-2542, December 2024
Licensed Posology for EYLEA® (aflibercept) 8 mg in the UK
with Sobha Sivaprasad
PP-EYL-GB-2543, December 2024
Patient Experiences with EYLEA® (aflibercept) 8 mg
with Serena Salvatore
PP-EYL-GB-2544, December 2024
Holistic Costs Associated with anti-VEGF Treatment
with Sobha Sivaprasad
PP-EYL-GB-2545, December 2024
Clinical Experience with EYLEA® (aflibercept) 8 mg
with Richard Gale
PP-EYL-GB-2546, December 2024
Guidance for Introducing EYLEA® (aflibercept) 8 mg into R...
with Serena Salvatore
PP-EYL-GB-2547, December 2024
Adverse Event Management for EYLEA® (aflibercept) 8 mg
with Richard Gale
PP-EYL-GB-2548, December 2024
Treatment Pathways for EYLEA® (aflibercept) 8 mg
with Rossella Anzidei
PP-EYL-GB-2549, December 2024
Practicalities of Using EYLEA® (aflibercept) 8 mg in Rout...
with Bhavin Maru
PP-EYL-GB-2550, January 2025
The Importance of Clinical Audits
with Hani Hasan
PP-EYL-GB-2551, December 2024
Drying Effects of EYLEA® (aflibercept) 8 mg
with Hani Hasan, Rossella Anzidei and Richard Gale
PP-EYL-GB-2552, December 2024
Bonus Episode
with All Speakers
PP-EYL-GB-2553, December 2024

Prescribing information for EYLEA® (aflibercept) can be found here.

PP-EYL-GB-2538 | January 2025